Publications by authors named "Viveca Gyberg"

Claim this Profile
M
Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population.
Giulia Ferrannini, Dirk De Bacquer, Iris Erlund, Viveca Gyberg, Kornelia Kotseva

Diabetes Care· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort.
Sara Meziani, Giulia Ferrannini, Mette Bjerre, Troels K Hansen, Viveca Ritsinger, Viveca Gyberg

Cardiovasc Diabetol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry.
Giulia Ferrannini, Dirk De Bacquer, Viveca Gyberg, Guy De Backer, Kornelia Kotseva

Diabetes Res Clin Pract· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.
Giulia Ferrannini, Dirk De Bacquer, Pieter Vynckier, Guy De Backer, Viveca Gyberg

Cardiovasc Diabetol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management.
Giulia Ferrannini, Anna Norhammar, Viveca Gyberg, Linda Mellbin, Lars Rydén

Diabetes Care· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study.
Dirk De Bacquer, Delphine De Smedt, Kornelia Kotseva, Catriona Jennings, David Wood, Viveca Gyberg

Eur J Epidemiol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2 cohort.
Maria Isabel Smáradóttir, Sergiu-Bogdan Catrina, Kerstin Brismar, Anna Norhammar, Viveca Gyberg

Diab Vasc Dis Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey.
Delphine De Smedt, Lieven Annemans, Guy De Backer, Kornelia Kotseva, Lars Rydèn, Viveca Gyberg

Int J Cardiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of different outreach strategies to identify individuals at high risk of diabetes in a heterogeneous population: a study in the Swedish municipality of Södertälje.
Bahira Shahim, Sofia Hasselberg, Oscar Boldt-Christmas, Viveca Gyberg, Linda Mellbin

Eur J Prev Cardiol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of testosterone levels in patients with newly detected glucose abnormalities and acute myocardial infarction.
Anne Wang, Stefan Arver, John Flanagan, Viveca Gyberg, Per Näsman

Diab Vasc Dis Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Accuracy of Point-of-Care Equipment for Glucose Measurement in Screening for Dysglycemia in Patients with Coronary Artery Disease.
Bahira Shahim, Barbro Kjellström, Viveca Gyberg, Catriona Jennings, Stina Smetana

Diabetes Technol Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Bahira Shahim, Viveca Gyberg, Dirk De Bacquer, Kornelia Kotseva, Guy De Backer

Cardiovasc Diabetol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.
Kornelia Kotseva, Dirk De Bacquer, Catriona Jennings, Viveca Gyberg, Guy De Backer

Glob Heart· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV: A Survey From the European Society of Cardiology.
Bahira Shahim, Dirk De Bacquer, Guy De Backer, Viveca Gyberg, Kornelia Kotseva

Diabetes Care· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.
Maria Isabel Smaradottir, Viveca Ritsinger, Viveca Gyberg, Anna Norhammar, Per Näsman

Diab Vasc Dis Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions.
Kornelia Kotseva, Dirk De Bacquer, Guy De Backer, Lars Rydén, Catriona Jennings, Viveca Gyberg

Eur J Prev Cardiol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.
Viveca Gyberg, Dirk De Bacquer, Kornelia Kotseva, Guy De Backer, Oliver Schnell

BMJ Open· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral glucose tolerance testing and cardiovascular disease.
Lars Rydén, Viveca Gyberg, Oliver Schnell, Jaakko Tuomilehto,

Lancet Diabetes Endocrinol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
Kornelia Kotseva, David Wood, Dirk De Bacquer, Guy De Backer, Lars Rydén, Viveca Gyberg

Eur J Prev Cardiol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of a Simplified Glucose Measurement Device--The HemoCue Glucose 201RT.
Ellen Segerhag, Viveca Gyberg, Kyriacos Ioannides, Catriona Jennings, Lars Rydén

Diabetes Technol Ther· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Viveca Gyberg, Dirk De Bacquer, Guy De Backer, Catriona Jennings, Kornelia Kotseva

Cardiovasc Diabetol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Lifestyle Trends Counter Improvements in Cardiovascular Risk Factor Management in Coronary Patients.
Kornelia Kotseva, Dirk De Bacquer, Catriona Jennings, Viveca Gyberg, Guy De Backer

J Am Coll Cardiol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Glucose impairment despite normal HbA1c or fasting plasma glucose].
Viveca Gyberg

Lakartidningen· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study.
Viveca Gyberg, Kornelia Kotseva, Jean Dallongeville, Guy De Backer, Linda Mellbin

Eur J Prev Cardiol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.
Viveca Gyberg, Dirk De Bacquer, Kornelia Kotseva, Guy De Backer, Oliver Schnell

Eur Heart J· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis